1 Min Read
May 18 (Reuters) - AstraZeneca PLC Pascal Soriot tells reporters:
* CEO SAYS STILL DON’T KNOW WHETHER WILL BE MUTUAL RECOGNITION FOR DRUG REGULATION AFTER BREXIT AND INDUSTRY NEEDS CLARITY Further company coverage: (Reporting by UK bureau)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.